✦ LIBER ✦

FDA clears Pall’s blood collection product

Book ID: 114310990
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 131 KB
Volume: 2003
Category: Article
ISSN: 0958-2118
DOI: 10.1016/s0958-2118(03)02016-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pall signs agreement to sell its blood c

Pall signs agreement to sell its blood collection, filtration and processing product lines to Haemonetics

📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 150 KB

Blood product collection and supply: a m

Blood product collection and supply: a matter of money?

✍ W. De Kort; E. Wagenmans; A. Van Dongen; Y. Slotboom; G. Hofstede; I. Veldhuizen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 280 KB

Impact of donor- and collection-related

Impact of donor- and collection-related variables on product quality in ex utero cord blood banking

✍ Sabeen Askari; John Miller; Gayl Chrysler; Jeffrey McCullough 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Collection of a mobilized peripheral blo

Collection of a mobilized peripheral blood apheresis product from a patient with mucopolysaccharidosis type VII and subsequent CD34+ cell isolation

✍ A. Alex Hofling; Mark S. Sands; Douglas M. Lublin; Gerhard Bauer; Steven Devine 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

## Abstract The effectiveness of bone marrow transplantation for lysosomal storage diseases like mucopolysaccharidosis type VII (MPSVII) suggests that a gene therapy strategy targeting autologous hematopoietic progenitor cells could be successful. Given the severe systemic manifestations of MPSVII